Bernardo Empis Meira
Partner @ BlueCrow Capital
Bernardo Empis Meira is a Series A investor at BlueCrow Capital focused on Farming and Seafood. Bernardo Empis Meira is the Partner at BlueCrow Capital. Bernardo Empis Meira attended New University of Lisbon.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Bernardo Empis Meira invests in
Stages Bernardo Empis Meira invests in
Countries Bernardo Empis Meira invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Farming 1 (33%)
- Seafood 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
- Food Processing 1 (33%)
Stage
- Series A 1 (33%)
- Venture - Series Unknown 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Oceano Fresco develops and produces bivalves varieties with superior performance for shellfish farmers at a competitive cost, respecting environmental sustainability and ensuring consumer safety.They use a multi-disciplinary approach including expertise in molecular biology, genetics, animal physiology, computational biology and intellectualproperty to select value adding traits to shellfish farmers and contribute to the sustainability and profitability of the aquaculture industry.They work with hatcheries, nurseries and research centers in order to test and validate their solutions and ensure that they suit the specific needs of each customer, in each technical and environmental context. | $18.4M / Venture - Series Unknown / Jul 25, 2024 | ||
| Ophiomics is an ISO 13485 and ISO 9001 certified, clinical-stage Medtech company developing cutting-edge diagnostic products and services integrating bioinformatics, artificial intelligence and genomics in support of diagnostic, prognostic, treatment selection and clinical follow-up in oncology. It currently has a rich pipeline of products atdifferent development stages, from pre-clinical programs to products undergoing clinical validation. | $6.5M / Series A / Jan 18, 2023 | ||
| Oceano Fresco develops and produces bivalves varieties with superior performance for shellfish farmers at a competitive cost, respecting environmental sustainability and ensuring consumer safety.They use a multi-disciplinary approach including expertise in molecular biology, genetics, animal physiology, computational biology and intellectualproperty to select value adding traits to shellfish farmers and contribute to the sustainability and profitability of the aquaculture industry.They work with hatcheries, nurseries and research centers in order to test and validate their solutions and ensure that they suit the specific needs of each customer, in each technical and environmental context. | $3M / Venture - Series Unknown / Nov 11, 2019 |
Co-Investors
About BlueCrow Capital
BlueCrow Capital is a venture capital firm.
BlueCrow Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bernardo Empis Meira
Partner
|
|||
António Mello Campello
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bernardo Empis Meira invest in?
Bernardo Empis Meira invests primarily in Farming, Seafood and Biotechnology startups, most often at Series A and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bernardo Empis Meira?
Public channels for Bernardo Empis Meira include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Bernardo Empis Meira last invest?
The most recent investment recorded for Bernardo Empis Meira closed in Jul 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
